Aducanumab: Promising Alzheimer’s drug or dangerous precedent?
The FDA has overruled the recommendations of its advisory panel, who were almost unanimously against approving the controversial drug.
Gene writing: The future of genetic medicine?
Tessera Therapeutics’ new technology could write therapeutic messages into genomes, treating genetic diseases at their...
Moderna’s new Covid-19 vaccine production facility gets EMA approval
The newly approved sites are expected to produce one to two million additional doses of the Moderna vaccine per month for the EU.
Bacterial “cell factories”: an eco-friendly approach to chemical production
Researchers at the University of Warwick have designed a genetic switch that reroutes bacteria’s chemistry to produce chemicals.
How is activity in the pharma sector recovering from Covid-19’s impact?
Analysis of jobs, deals, stock prices and financial filings and news sentiments now show pharma to be a relative winner when it comes to Covid-19 recovery.
Latest Deals
-
Umoja BiopharmaCapital Raising $210M
-
HiFiBiOCapital Raising $75M
-
GSKPartnership $2BN
-
AbbViePartnership $267M
-
Umoja BiopharmaCapital Raising $210M
-
HiFiBiOCapital Raising $75M
-
GSKPartnership $2BN
-
AbbViePartnership $267M
Pharma company stocks have recovered slower than average since the pandemic began
The top 10 countries for cloud computing job adds from pharmaceutical companies in 2021 (Source: GlobalData)
Countries posting the most cloud computing job ads in the pharmaceutical sector during 2021
| Country | Cloud computing job ads in 2021 |
|---|---|
| United States | 470 |
| India | 145 |
| Poland | 43 |
| Slovakia | 35 |
| Mexico | 27 |
| United Kingdom | 24 |
| Germany | 20 |
| Canada | 12 |
| Hungary | 12 |
| Spain | 11 |
Latest News
Umoja Biopharma raises $210m to develop cancer treatments
The funds will also be used to set up internal manufacturing capabilities to clinically develop pipeline programmes.
FDA approves Mallinckrodt’s StrataGraft for thermal burns treatment
The approval of Mallinckrodt’s StrataGraft is backed by positive data from a Phase III trial in patients with deep partial-thickness burns.
NRx Pharmaceuticals’ Zyesami yields positive data in EAP for Covid-19
Participants who received at least one dose of Zyesami along with intensive care were alive at 28 days.
HiFiBiO raises series D funds to advance immuno-oncology candidates
HiFiBiO Therapeutics plans to accelerate two immuno-oncology programmes and to validate its Drug Intelligent Science platform in clinical trials.
Latest Themes
AI will be the dominant disrupting technology in upcoming two years: Survey
The pharmaceutical industry is heavily investing in artificial intelligence (AI) to enhance efficiency and deliver pipeline candidates.
AI and Big Data expected to garner maximum investment over next two years
In the past few years, the pharmaceutical industry recorded increasing investment in several emerging technologies for operation enablement and innovation.
Covid and Big Tech are driving Augmented Reality into healthcare
Augmented Reality tech is helping hospitals to deliver better patient care while at the same time cutting down on Covid infection danger, as Giacomo Lee reports.
Robots make more business sense with AI – just don’t expect fireworks
Robot use is becoming increasingly practical, which means that such machinery is being increasingly employed – and AI can only make robotics better, as Giacomo Lee finds out.
Robots make more business sense with AI – just don’t expect fireworks
Robot use is becoming increasingly practical, which means that such machinery is being increasingly employed – and AI can only make robotics better, as Giacomo Lee finds out.
Utilisation of RWE can help in managing COVID-19 outbreak: Poll
With COVID-19 pandemic continuing unabated, the opinion of using Real World Evidence (RWE) to control infectious diseases has further gained traction.
Big data and AI are likely to lead emerging technology investments: Survey
With digital transformation gradually picking up pace, the pharmaceutical industry has witnessed an increase in investment in emerging technologies.
Digital transformation: Investment in cybersecurity remain stable
Investment in cybersecurity amid the growing pace of digital transformation has remained relatively stable in the pharmaceutical industry.
Expert Commentary & Analysis
View MoreEmployers fear wage inflation and demanding employees – leading macroeconomic influencers
Some sectors such as hospitality are worried over labour shortages and higher pay offers amid...
FDA declines to approve Avenue’s intravenous use of tramadol
FDA cites delayed and unpredictable onset of analgesia as the reason for rejecting IV tramadol...
Covid-19 vaccinations lead to substantial increase in GDP – leading macroeconomic influencers
Accelerated Covid-19 vaccination efforts can lead to significant increase in GDP relative to the cost...
US workers’ high quit rate stings employers – leading macroeconomic influencers
US companies are witnessing a wave of resignations in 2021 as the pandemic fades, leading...